Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The requirement for proteomics to unravel stem cell regulatory mechanisms.

Williamson AJ, Whetton AD.

J Cell Physiol. 2011 Oct;226(10):2478-83. doi: 10.1002/jcp.22610. Review.

PMID:
21792904
2.

Systems biology provides new insights into the molecular mechanisms that control the fate of embryonic stem cells.

Mallanna SK, Rizzino A.

J Cell Physiol. 2012 Jan;227(1):27-34. doi: 10.1002/jcp.22721. Review.

3.

Defining pluripotent stem cells through quantitative proteomic analysis.

Reiland S, Salekdeh GH, Krijgsveld J.

Expert Rev Proteomics. 2011 Feb;8(1):29-42. doi: 10.1586/epr.10.100. Review.

PMID:
21329426
4.

Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells.

Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, Jan T, Wilson KD, Leong D, Rosenberg J, Yao M, Robbins RC, Wu JC.

J Clin Invest. 2011 Mar;121(3):1217-21. doi: 10.1172/JCI44635. Epub 2011 Feb 7.

5.

Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells.

Chen HF, Chuang CY, Lee WC, Huang HP, Wu HC, Ho HN, Chen YJ, Kuo HC.

Stem Cell Rev. 2011 Sep;7(3):722-35. doi: 10.1007/s12015-011-9233-y.

PMID:
21305366
6.

β-catenin enhances Oct-4 activity and reinforces pluripotency through a TCF-independent mechanism.

Kelly KF, Ng DY, Jayakumaran G, Wood GA, Koide H, Doble BW.

Cell Stem Cell. 2011 Feb 4;8(2):214-27. doi: 10.1016/j.stem.2010.12.010.

7.

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR.

Nature. 2011 Mar 3;471(7336):68-73. doi: 10.1038/nature09798. Epub 2011 Feb 2. Erratum in: Nature. 2014 Oct 2;514(7520):126.

8.

Global expression of cell surface proteins in embryonic stem cells.

Gu B, Zhang J, Wang W, Mo L, Zhou Y, Chen L, Liu Y, Zhang M.

PLoS One. 2010 Dec 29;5(12):e15795. doi: 10.1371/journal.pone.0015795.

9.

Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts.

Jin J, Kwon YW, Paek JS, Cho HJ, Yu J, Lee JY, Chu IS, Park IH, Park YB, Kim HS, Kim Y.

J Proteome Res. 2011 Mar 4;10(3):977-89. doi: 10.1021/pr100624f. Epub 2011 Feb 4.

PMID:
21175196
10.

Large scale phosphoproteome profiles comprehensive features of mouse embryonic stem cells.

Li QR, Xing XB, Chen TT, Li RX, Dai J, Sheng QH, Xin SM, Zhu LL, Jin Y, Pei G, Kang JH, Li YX, Zeng R.

Mol Cell Proteomics. 2011 Apr;10(4):M110.001750. doi: 10.1074/mcp.M110.001750. Epub 2010 Dec 13.

11.

Tissue-resident adult stem cell populations of rapidly self-renewing organs.

Barker N, Bartfeld S, Clevers H.

Cell Stem Cell. 2010 Dec 3;7(6):656-70. doi: 10.1016/j.stem.2010.11.016. Review.

12.

Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.

Li Y, Zhang Q, Yin X, Yang W, Du Y, Hou P, Ge J, Liu C, Zhang W, Zhang X, Wu Y, Li H, Liu K, Wu C, Song Z, Zhao Y, Shi Y, Deng H.

Cell Res. 2011 Jan;21(1):196-204. doi: 10.1038/cr.2010.142. Epub 2010 Oct 19.

13.

Proteomic studies of stem cells.

Wang J, Trowbridge JJ, Rao S, Orkin SH.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2008 Jul 14.

14.

Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells.

Hofmann A, Gerrits B, Schmidt A, Bock T, Bausch-Fluck D, Aebersold R, Wollscheid B.

Blood. 2010 Sep 30;116(13):e26-34. doi: 10.1182/blood-2010-02-271270. Epub 2010 Jun 22.

15.

Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation.

Tian R, Wang S, Elisma F, Li L, Zhou H, Wang L, Figeys D.

Mol Cell Proteomics. 2011 Feb;10(2):M110.000679. doi: 10.1074/mcp.M110.000679. Epub 2010 Jun 8.

16.

Functional heterogeneity of embryonic stem cells revealed through translational amplification of an early endodermal transcript.

Canham MA, Sharov AA, Ko MS, Brickman JM.

PLoS Biol. 2010 May 25;8(5):e1000379. doi: 10.1371/journal.pbio.1000379.

17.

Expanding the mouse embryonic stem cell proteome: combining three proteomic approaches.

Gundry RL, Tchernyshyov I, Sheng S, Tarasova Y, Raginski K, Boheler KR, Van Eyk JE.

Proteomics. 2010 Jul;10(14):2728-32. doi: 10.1002/pmic.201000039.

18.

Pluripotency of human embryonic and induced pluripotent stem cells for cardiac and vascular regeneration.

Boheler KR.

Thromb Haemost. 2010 Jul;104(1):23-9. doi: 10.1160/TH09-07-0507. Epub 2010 May 10. Review.

PMID:
20458433
19.

Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity.

Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, Kim HS, Park IH, Daley GQ, Hwang DY, Kim DW.

Stem Cell Rev. 2010 Jun;6(2):270-81. doi: 10.1007/s12015-010-9138-1. Erratum in: Stem Cell Rev. 2010 Jun;6(2):334.

PMID:
20376579
20.

An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.

Pardo M, Lang B, Yu L, Prosser H, Bradley A, Babu MM, Choudhary J.

Cell Stem Cell. 2010 Apr 2;6(4):382-95. doi: 10.1016/j.stem.2010.03.004.

Supplemental Content

Support Center